CONMED (CNMD) Fundamental Analysis: Revenue, Earnings & Valuation

6.92 / 10

Outperform

Fundamental analysis rates CNMD as Outperform with a 6.9/10 score (6.92 overall). Profit‑MV and Cash‑MV are strong, while Revenue‑MV lags. Asset‑MV is modestly negative. Overall fundamentals are solid, supporting a positive outlook.

Analysis Checks(9/10)

Revenue-MV

Value0.77

Score1/3

Weight-6.23%

1M Return-0.97%

ROA (%)

Value2.03

Score2/3

Weight4.52%

1M Return0.64%

Net cash flow from operating activities / Operating revenue (%)

Value12.42

Score3/3

Weight12.43%

1M Return1.63%

Profit-MV

Value0.44

Score2/3

Weight23.16%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value2.03

Score2/3

Weight4.52%

1M Return0.64%

EBIT / Total operating revenue (%)

Value7.43

Score3/3

Weight11.53%

1M Return1.53%

Asset-MV

Value-0.55

Score2/3

Weight3.96%

1M Return0.57%

Net profit / Total operating revenue (%)

Value3.42

Score3/3

Weight10.31%

1M Return1.41%

Cash-MV

Value0.14

Score3/3

Weight23.10%

1M Return2.92%

Net profit / Total profit (%)

Value66.17

Score3/3

Weight12.71%

1M Return1.76%

Is CNMD fundamentally strong?

CNMD scores 6.92/10 on fundamentals and holds a Discounted valuation at present. Backed by its 4.72% ROE, 3.42% net margin, 23.17 P/E ratio, 1.06 P/B ratio, and -64.57% earnings growth, these metrics solidify its Outperform investment rating.